• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ADO
Click for more information
0.00% 2.1¢

ANTEOTECH LTD - Announcements

Market Cap $54.77M  ! watchlist Created with Sketch. Add to my watchlist

AnteoTech Limited is an Australia-based company engaged in providing solutions for the... AnteoTech Limited is an Australia-based company engaged in providing solutions for the clean energy and life sciences markets using applied materials technology. The principal activities of the Company consist of development and commercialization of nanotechnologies with surface management applications. The Company’s lead product, Anteo X, provides significant improvement in anode performance and the Company partners with global suppliers in lithium-ion battery manufacturing. Its clean energy technology (CET) technologies improve the energy densities, cycle life and cost- effectiveness of lithium-ion batteries. The Company has two programs underway: Anteo X, its binder additive and the High Silicon Anode technology. The Life Sciences division services the point-of-care and in vitro diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
ADO Anteo Secures Working Capital & Extension to Earn OutPRICE SENSITIVE06/04/17
ADO Correction to Appendix 4D28/03/17
ADO Anteo Presents at Largest IVD Trade Show in China13/03/17
ADO Verification Study with Cook Medical AustraliaPRICE SENSITIVE07/03/17
ADO Half Yearly Report and AccountsPRICE SENSITIVE27/02/17
ADO Appendix 3B21/02/17
ADO Appendix 4C - quarterlyPRICE SENSITIVE31/01/17
ADO DIAsource Outperforms Expectations for CY2016PRICE SENSITIVE30/01/17
ADO DIAsource Receives Grant to Develop Free Vitamin D AssayPRICE SENSITIVE25/01/17
ADO Vendor Finance Payment17/01/17
ADO Strengthening IP in Medical DevicesPRICE SENSITIVE12/01/17
ADO Ceasing to be a substantial holder12/01/17
ADO Ceasing to be a substantial holder11/01/17
ADO Change in substantial holding08/12/16
ADO Appointment of Chairman30/11/16
ADO Results of 2016 AGM15/11/16
ADO AGM Presentation14/11/16
ADO Chairman Not To Seek Re-election at AGM14/11/16
ADO Anteo Signs Collaboration Agreement on Novel PoC PlatformPRICE SENSITIVE11/11/16
ADO Anteo becomes a Supporting Participant with DMTCPRICE SENSITIVE11/11/16
ADO Appendix 4C - quarterly-ADO.AX PRICE SENSITIVE31/10/16
ADO Agreement with Next Generation PoC Company-ADO.AX PRICE SENSITIVE28/10/16
ADO Updated Corporate Governance Statement-ADO.AX 26/10/16
ADO Notice of General Meeting/Proxy Form-ADO.AX 14/10/16
ADO Corporate Governance Statement - Appendix 4G-ADO.AX 07/10/16
ADO Corrections to 2016 Annual Report-ADO.AX 07/10/16
ADO Group Chief Financial Officer appointment-ADO.AX 04/10/16
ADO Annual Report to shareholders-ADO.AX 30/09/16
ADO Anteo R&D Tax Incentive received-ADO.AX PRICE SENSITIVE09/09/16
ADO Revised Appendix 4E-ADO.AX PRICE SENSITIVE01/09/16
ADO Appendix 4E-ADO.AX PRICE SENSITIVE31/08/16
ADO Appendix 3Z-ADO.AX 29/08/16
ADO Anteo Board Changes-ADO.AX 28/08/16
ADO Anteo Board Changes-ADO.AX 25/08/16
ADO Becoming a substantial holder-ADO.AX 22/08/16
ADO Section 708A(5)(e) Notice-ADO.AX 22/08/16
ADO Appendix 3B-ADO.AX 22/08/16
ADO Section 708A(5)(e) Notice-ADO.AX 04/08/16
ADO Appendix 3B-ADO.AX 03/08/16
ADO New Products launched at AACC 2016-ADO.AX PRICE SENSITIVE02/08/16
ADO Appendix 3B-ADO.AX 01/08/16
ADO Appendix 4C - quarterly-ADO.AX PRICE SENSITIVE29/07/16
ADO APPOINTMENT OF COO Australian Operations-ADO.AX 27/07/16
ADO Appendix 3B-ADO.AX 08/07/16
ADO Amended Appendix 3Y-ADO.AX 04/07/16
ADO Anteo and Atomo partner to develop a POC Test-ADO.AX PRICE SENSITIVE15/06/16
ADO Commencement of new CEO-ADO.AX 14/06/16
ADO Appendix 4C - quarterly-ADO.AX 29/04/16
ADO Quarterly Cashflow Report-ADO.AX PRICE SENSITIVE29/04/16
ADO Response to Price Query-ADO.AX PRICE SENSITIVE27/04/16
ADO ANTEO PROGRESSES TO PCT ON BATTERY COMPOSITION PATENT-ADO.AX PRICE SENSITIVE21/04/16
ADO Anteo Files Patents in Electrochemical and Related Fields-ADO.AX PRICE SENSITIVE12/04/16
ADO Amended Appendix 3B30/03/16
ADO Section 708A Notice17/03/16
ADO ANTEO ANNOUNCES RETIREMENT OF CEOPRICE SENSITIVE16/03/16
ADO S&P DJ Indices Announces March Quarterly Review11/03/16
ADO Appendix 3B09/03/16
ADO Section 708A(5)(e) Notice03/03/16
ADO Appendix 3B03/03/16
ADO Anteo secures Investment Agreement with US based BergenPRICE SENSITIVE03/03/16
ADO Interim Financial Report 31 December 2015PRICE SENSITIVE29/02/16
ADO Substantial Shareholder Notice23/02/16
ADO Appendix 3B02/02/16
ADO Appendix 3X02/02/16
ADO Quarterly Activities and Cashflow report - Appendix 4CPRICE SENSITIVE29/01/16
ADO Section 708 Cleansing Notice15/01/16
ADO Appendix 3Y14/01/16
ADO Appendix 3B13/01/16
ADO Anteo completes acquisition of DIAsource Immunoassays SAPRICE SENSITIVE12/01/16
ADO Revised Terms DIAsource acquisitionPRICE SENSITIVE06/01/16
ADO Reinstatement to Official QuotationPRICE SENSITIVE06/01/16
ADO Suspension from Official QuotationPRICE SENSITIVE05/01/16
ADO Trading HaltPRICE SENSITIVE31/12/15
ADO Distribution Schedule - Fully Paid Ordinary Shares29/12/15
ADO Top 20 Fully Paid Ordinary Shareholders29/12/15
ADO Appendix 3B29/12/15
ADO Anteo closes Entitlement OfferPRICE SENSITIVE23/12/15
ADO Approval of Convertible Note FacilityPRICE SENSITIVE18/12/15
ADO Extension of Entitlement Issue Offer Period11/12/15
ADO Shareholder Information Sessions04/12/15
ADO Boardroom Radio Interview with Dr Geoff Cumming01/12/15
ADO Section 708 AA (2) (f) Cleansing Notice30/11/15
ADO Appendix 3B30/11/15
ADO Offer DocumentPRICE SENSITIVE30/11/15
ADO ADO Proposed Funding PackagePRICE SENSITIVE30/11/15
ADO Appendix 3B19/11/15
ADO 2015 AGM Results09/11/15
ADO 2015 AGM Presentation09/11/15
ADO 2015 AGM Chairmans Address09/11/15
ADO Appendix 4C September Quarterly 2015PRICE SENSITIVE30/10/15
ADO Anteo and Koma enter into Distribution AgreementPRICE SENSITIVE19/10/15
ADO Amended 2015 Notice of Annual General Meeting12/10/15
ADO Proxy Form 2015 AGM12/10/15
ADO Notice of Annual General Meeting 201512/10/15
ADO Corporate Goverance Statement16/09/15
ADO Appendix 4G16/09/15
ADO 2015 Annual Report26/08/15
ADO Appendix 4EPRICE SENSITIVE26/08/15
ADO Boardroom Radio Interview with Dr Geoff Cumming26/08/15
ADO Anteo to acquire Global Diagnostics Company - DIAsourcePRICE SENSITIVE26/08/15
ADO Anteo Secures Working Capital & Extension to Earn Out
06/04/17PRICE SENSITIVE
ADO Correction to Appendix 4D
28/03/17
ADO Anteo Presents at Largest IVD Trade Show in China
13/03/17
ADO Verification Study with Cook Medical Australia
07/03/17PRICE SENSITIVE
ADO Half Yearly Report and Accounts
27/02/17PRICE SENSITIVE
ADO Appendix 3B
21/02/17
ADO Appendix 4C - quarterly
31/01/17PRICE SENSITIVE
ADO DIAsource Outperforms Expectations for CY2016
30/01/17PRICE SENSITIVE
ADO DIAsource Receives Grant to Develop Free Vitamin D Assay
25/01/17PRICE SENSITIVE
ADO Vendor Finance Payment
17/01/17
ADO Strengthening IP in Medical Devices
12/01/17PRICE SENSITIVE
ADO Ceasing to be a substantial holder
12/01/17
ADO Ceasing to be a substantial holder
11/01/17
ADO Change in substantial holding
08/12/16
ADO Appointment of Chairman
30/11/16
ADO Results of 2016 AGM
15/11/16
ADO AGM Presentation
14/11/16
ADO Chairman Not To Seek Re-election at AGM
14/11/16
ADO Anteo Signs Collaboration Agreement on Novel PoC Platform
11/11/16PRICE SENSITIVE
ADO Anteo becomes a Supporting Participant with DMTC
11/11/16PRICE SENSITIVE
ADO Appendix 4C - quarterly-ADO.AX
31/10/16PRICE SENSITIVE
ADO Agreement with Next Generation PoC Company-ADO.AX
28/10/16PRICE SENSITIVE
ADO Updated Corporate Governance Statement-ADO.AX
26/10/16
ADO Notice of General Meeting/Proxy Form-ADO.AX
14/10/16
ADO Corporate Governance Statement - Appendix 4G-ADO.AX
07/10/16
ADO Corrections to 2016 Annual Report-ADO.AX
07/10/16
ADO Group Chief Financial Officer appointment-ADO.AX
04/10/16
ADO Annual Report to shareholders-ADO.AX
30/09/16
ADO Anteo R&D Tax Incentive received-ADO.AX
09/09/16PRICE SENSITIVE
ADO Revised Appendix 4E-ADO.AX
01/09/16PRICE SENSITIVE
ADO Appendix 4E-ADO.AX
31/08/16PRICE SENSITIVE
ADO Appendix 3Z-ADO.AX
29/08/16
ADO Anteo Board Changes-ADO.AX
28/08/16
ADO Anteo Board Changes-ADO.AX
25/08/16
ADO Becoming a substantial holder-ADO.AX
22/08/16
ADO Section 708A(5)(e) Notice-ADO.AX
22/08/16
ADO Appendix 3B-ADO.AX
22/08/16
ADO Section 708A(5)(e) Notice-ADO.AX
04/08/16
ADO Appendix 3B-ADO.AX
03/08/16
ADO New Products launched at AACC 2016-ADO.AX
02/08/16PRICE SENSITIVE
ADO Appendix 3B-ADO.AX
01/08/16
ADO Appendix 4C - quarterly-ADO.AX
29/07/16PRICE SENSITIVE
ADO APPOINTMENT OF COO Australian Operations-ADO.AX
27/07/16
ADO Appendix 3B-ADO.AX
08/07/16
ADO Amended Appendix 3Y-ADO.AX
04/07/16
ADO Anteo and Atomo partner to develop a POC Test-ADO.AX
15/06/16PRICE SENSITIVE
ADO Commencement of new CEO-ADO.AX
14/06/16
ADO Appendix 4C - quarterly-ADO.AX
29/04/16
ADO Quarterly Cashflow Report-ADO.AX
29/04/16PRICE SENSITIVE
ADO Response to Price Query-ADO.AX
27/04/16PRICE SENSITIVE
ADO ANTEO PROGRESSES TO PCT ON BATTERY COMPOSITION PATENT-ADO.AX
21/04/16PRICE SENSITIVE
ADO Anteo Files Patents in Electrochemical and Related Fields-ADO.AX
12/04/16PRICE SENSITIVE
ADO Amended Appendix 3B
30/03/16
ADO Section 708A Notice
17/03/16
ADO ANTEO ANNOUNCES RETIREMENT OF CEO
16/03/16PRICE SENSITIVE
ADO S&P DJ Indices Announces March Quarterly Review
11/03/16
ADO Appendix 3B
09/03/16
ADO Section 708A(5)(e) Notice
03/03/16
ADO Appendix 3B
03/03/16
ADO Anteo secures Investment Agreement with US based Bergen
03/03/16PRICE SENSITIVE
ADO Interim Financial Report 31 December 2015
29/02/16PRICE SENSITIVE
ADO Substantial Shareholder Notice
23/02/16
ADO Appendix 3B
02/02/16
ADO Appendix 3X
02/02/16
ADO Quarterly Activities and Cashflow report - Appendix 4C
29/01/16PRICE SENSITIVE
ADO Section 708 Cleansing Notice
15/01/16
ADO Appendix 3Y
14/01/16
ADO Appendix 3B
13/01/16
ADO Anteo completes acquisition of DIAsource Immunoassays SA
12/01/16PRICE SENSITIVE
ADO Revised Terms DIAsource acquisition
06/01/16PRICE SENSITIVE
ADO Reinstatement to Official Quotation
06/01/16PRICE SENSITIVE
ADO Suspension from Official Quotation
05/01/16PRICE SENSITIVE
ADO Trading Halt
31/12/15PRICE SENSITIVE
ADO Distribution Schedule - Fully Paid Ordinary Shares
29/12/15
ADO Top 20 Fully Paid Ordinary Shareholders
29/12/15
ADO Appendix 3B
29/12/15
ADO Anteo closes Entitlement Offer
23/12/15PRICE SENSITIVE
ADO Approval of Convertible Note Facility
18/12/15PRICE SENSITIVE
ADO Extension of Entitlement Issue Offer Period
11/12/15
ADO Shareholder Information Sessions
04/12/15
ADO Boardroom Radio Interview with Dr Geoff Cumming
01/12/15
ADO Section 708 AA (2) (f) Cleansing Notice
30/11/15
ADO Appendix 3B
30/11/15
ADO Offer Document
30/11/15PRICE SENSITIVE
ADO ADO Proposed Funding Package
30/11/15PRICE SENSITIVE
ADO Appendix 3B
19/11/15
ADO 2015 AGM Results
09/11/15
ADO 2015 AGM Presentation
09/11/15
ADO 2015 AGM Chairmans Address
09/11/15
ADO Appendix 4C September Quarterly 2015
30/10/15PRICE SENSITIVE
ADO Anteo and Koma enter into Distribution Agreement
19/10/15PRICE SENSITIVE
ADO Amended 2015 Notice of Annual General Meeting
12/10/15
ADO Proxy Form 2015 AGM
12/10/15
ADO Notice of Annual General Meeting 2015
12/10/15
ADO Corporate Goverance Statement
16/09/15
ADO Appendix 4G
16/09/15
ADO 2015 Annual Report
26/08/15
ADO Appendix 4E
26/08/15PRICE SENSITIVE
ADO Boardroom Radio Interview with Dr Geoff Cumming
26/08/15
ADO Anteo to acquire Global Diagnostics Company - DIAsource
26/08/15PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
2.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $54.77M
Open High Low Value Volume
2.1¢ 2.2¢ 2.1¢ $6.966K 328.9K

Buyers (Bids)

No. Vol. Price($)
1 235436 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 642018 2
View Market Depth
Last trade - 15.43pm 30/09/2024 (20 minute delay) ?
Last
2.1¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
2.2¢ 2.2¢ 2.1¢ 216911
Last updated 15.32pm 30/09/2024 ?
ADO (ASX) Chart

Top Stories

The iron ore comeback: Can it last?

The Chinese need our iron ore and we could do with the cash if we are sensible enough to put the stuff on a boat and sell it to them.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Hastings progressing Yangibana to production with lower costs Hastings Technology Metals Ltd has released its annual report to shareholders, saying that it has reduced capital costs by $56 million
Zenith's sale of Develin Creek delivers $975K cash, with shares up 13% Zenith Minerals Ltd has completed its sale of Develin Creek copper-zinc project in Queensland to QMines Ltd
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.